This page has been archived on the Web
Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.
Lorazepam 0.5 mg (2017-02-09)
- Starting date:
- February 9, 2017
- Posting date:
- February 22, 2017
- Type of communication:
- Drug Recall
- Subcategory:
- Drugs
- Hazard classification:
- Type III
- Source of recall:
- Health Canada
- Issue:
- Product Safety
- Audience:
- General Public, Healthcare Professionals, Hospitals
- Identification number:
- RA-62300
Reason
Out of specification result for Organic Impurity - USP Related Compound C during stability testing.
Depth of distribution
Alberta, British Columbia, Manitoba, New Brunswick, Newfoundland, Nova Scotia, Prince Edward Island, Quebec and Saskatchewan.
Affected products
Lorazepam 0.5 mg
DIN, NPN, DIN-HIM
DIN 02351072
Dosage form
Tablet
Strength
0.5 mg
Lot or serial number
35342323B
35343041B
Companies
- Recalling Firm
-
Sanis Health
243 Consumers Road
Toronto
M2J 4W8
Ontario
CANADA
- Marketing Authorization Holder
-
Sanis Health
243 Consumers Road
Toronto
M2J 4W8
Ontario
CANADA